Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-25 @ 9:49 PM
Study NCT ID:
NCT00283751
Status:
COMPLETED
Last Update Posted:
2017-01-27
First Post:
2006-01-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
2004-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-27
First Submit QC Date:
None
Study First Post Date:
2006-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-26
Last Update Post Date:
2017-01-27
Last Update Post Date Type:
ESTIMATED